Approvals/TGA/SYNAGIS palivizumab (rmc) 50 mg / 0.5 mL solution for injection vial

Approved

STANDARD

SYNAGIS palivizumab (rmc) 50 mg / 0.5 mL solution for injection vial

AstraZeneca Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 5d8db2d01b5ffb00
Product Name: SYNAGIS palivizumab (rmc) 50 mg / 0.5 mL solution for injection vial
Artg Id: 231133
Artg Name: SYNAGIS palivizumab (rmc) 50 mg / 0.5 mL solution for injection vial
Sponsor: AstraZeneca Pty Ltd
Company Detail Path: /organization/astrazeneca-pty-ltd
Artg Date: 2015-09-24
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/936d77d5227fba45c45dafaeb2eed1d0.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/8c895aad32fe407c41d3c2b6106f1fde.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

5d8db2d01b5ffb00

Type

Standard